CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022		30,801,912
Beginning balance at Dec. 31, 2022	$ 1,110,868	$ 31	$ 651,004	$ 458,356	$ 1,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	11,530			11,530
Unrealized gain (loss) on investment, net of taxes	93				93
Stock-based compensation	1,177		1,199	(22)
Issuance of restricted and deferred stock units (in shares)		38,776
Issuance of restricted and deferred stock units	(1,538)		(1,538)
Employee stock purchase plan (in shares)		16,410
Employee stock purchase plan	1,080		1,080
Common stock issuance, net of costs (in shares)		570,026
Common stock issuance, net of costs	40,997		40,997
Dividends paid	(11,722)			(11,722)
Ending balance (in shares) at Mar. 31, 2023		31,427,124
Ending balance at Mar. 31, 2023	1,152,485	$ 31	692,742	458,142	1,570
Beginning balance (in shares) at Dec. 31, 2022		30,801,912
Beginning balance at Dec. 31, 2022	1,110,868	$ 31	651,004	458,356	1,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	66,038
Ending balance (in shares) at Sep. 30, 2023		31,933,003
Ending balance at Sep. 30, 2023	1,220,253	$ 32	729,740	488,585	1,896
Beginning balance (in shares) at Mar. 31, 2023		31,427,124
Beginning balance at Mar. 31, 2023	1,152,485	$ 31	692,742	458,142	1,570
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	18,286			18,286
Unrealized gain (loss) on investment, net of taxes	8				8
Stock-based compensation	1,122		1,139	(17)
Issuance of restricted and deferred stock units (in shares)		13,429
Issuance of restricted and deferred stock units	(20)		(20)
Common stock issuance, net of costs (in shares)		290,477
Common stock issuance, net of costs	22,782	$ 1	22,781
Dividends paid	(11,947)			(11,947)
Ending balance (in shares) at Jun. 30, 2023		31,731,030
Ending balance at Jun. 30, 2023	1,182,716	$ 32	716,642	464,464	1,578
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	36,222			36,222
Unrealized gain (loss) on investment, net of taxes	318				318
Stock-based compensation	1,230		1,238	(8)
Issuance of restricted and deferred stock units (in shares)		14,840
Issuance of restricted and deferred stock units	(706)		(706)
Employee stock purchase plan (in shares)		17,712
Employee stock purchase plan	1,061		1,061
Common stock issuance, net of costs (in shares)		169,421
Common stock issuance, net of costs	11,505		11,505
Dividends paid	(12,093)			(12,093)
Ending balance (in shares) at Sep. 30, 2023		31,933,003
Ending balance at Sep. 30, 2023	$ 1,220,253	$ 32	729,740	488,585	1,896
Beginning balance (in shares) at Dec. 31, 2023	32,023,004	32,023,004
Beginning balance at Dec. 31, 2023	$ 1,233,397	$ 32	736,191	495,383	1,791
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	11,699			11,699
Unrealized gain (loss) on investment, net of taxes	(442)				(442)
Stock-based compensation	1,529		1,538	(9)
Issuance of restricted and deferred stock units (in shares)		30,432
Issuance of restricted and deferred stock units	(1,215)		(1,215)
Employee stock purchase plan (in shares)		21,755
Employee stock purchase plan	1,101		1,101
Common stock issuance, net of costs (in shares)		126,025
Common stock issuance, net of costs	7,006		7,006
Dividends paid	(12,824)			(12,824)
Ending balance (in shares) at Mar. 31, 2024		32,201,216
Ending balance at Mar. 31, 2024	$ 1,240,251	$ 32	744,621	494,249	1,349
Beginning balance (in shares) at Dec. 31, 2023	32,023,004	32,023,004
Beginning balance at Dec. 31, 2023	$ 1,233,397	$ 32	736,191	495,383	1,791
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 71,047
Ending balance (in shares) at Sep. 30, 2024	33,226,735	33,226,735
Ending balance at Sep. 30, 2024	$ 1,333,805	$ 33	804,848	527,575	1,349
Beginning balance (in shares) at Mar. 31, 2024		32,201,216
Beginning balance at Mar. 31, 2024	1,240,251	$ 32	744,621	494,249	1,349
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	20,696			20,696
Stock-based compensation	1,267		1,275	(8)
Issuance of restricted and deferred stock units (in shares)		9,083
Issuance of restricted and deferred stock units	(2)		(2)
Common stock issuance, net of costs (in shares)		458,605
Common stock issuance, net of costs	25,296	$ 1	25,295
Dividends paid	(12,900)			(12,900)
Ending balance (in shares) at Jun. 30, 2024		32,668,904
Ending balance at Jun. 30, 2024	1,274,608	$ 33	771,189	502,037	1,349
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	38,652			38,652
Stock-based compensation	1,558		1,566	(8)
Issuance of restricted and deferred stock units (in shares)		1,388
Issuance of restricted and deferred stock units	(1)		(1)
Employee stock purchase plan (in shares)		21,098
Employee stock purchase plan	1,087		1,087
Common stock issuance, net of costs (in shares)		535,345
Common stock issuance, net of costs	31,007		31,007
Dividends paid	$ (13,106)			(13,106)
Ending balance (in shares) at Sep. 30, 2024	33,226,735	33,226,735
Ending balance at Sep. 30, 2024	$ 1,333,805	$ 33	$ 804,848	$ 527,575	$ 1,349